Skip to main content
. Author manuscript; available in PMC: 2014 Sep 13.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008041. doi: 10.1002/14651858.CD008041.pub2

Summary of results B.

Use of rescue medication

Placebo comparators Studies Attacks treated Treatment (%) Comparator (%) Relative risk (95% CI) NNTp (95% CI)
Aspirin (m± metoclopramide) versus placebo 8 2922 44 65 0.68 (0.63 to 0.73) 4 8 (4.1 to 5.7)
Aspirin 1000 mg versus placebo 5 1881 42 63 0.67 (0.61 to 0.73) 4.8 (3.9 to 6.0)
Aspirin 900 mg plus metoclopramide 10 mg versus placebo 3 1041 48 69 0.69 (0.62 to 0.77) 4.7 (3.7 to 6.5)
Active comparators Studies Attacks treated Treatment (%) Comparator (%) Relative risk (95% CI) NNH (95% CI)
Aspirin (± metoclopramide) versus sumatriptan 50 mg or 100 mg 4 1340 49 43 1.1 (1.01 to 1.3) 17 (8.8 to 140)
Aspirin 1000 mg versus sumatriptan 50 mg 2 726 44 40 1.1 (0.92 to 1.3) Not calculated
Aspirin 900 mg plus metoclopramide 10 mg versus sumatriptan 100 mg 2 614 55 46 1.2 (1.01 to 1.4) 11 (6.0 to 120)